Browsing "제약산업학과" byTitle

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 3 to 16 of 16

Issue DateTitleAuthor(s)Type
2020Factors affecting the self-rated health of immigrant women married to native men and raising children in South Korea: a cross-sectional study손경복Article
2019How Much Time Before Attempting Compulsory Licensing of Pharmaceuticals? A Non-parametric Event History Model With P-splines손경복Article
2019Importance of the intellectual property system in attempting compulsory licensing of pharmaceuticals: A cross-sectional analysis손경복Article
2020Is greater generic competition also linked to lower drug prices in South Korea?손경복Article
2021Manufacturers' perceptions of the decision-making process for new drug reimbursement in South Korea손경복Article
2018Moderating the impact of patent linkage on access to medicines: lessons from variations in South Korea, Australia, Canada, and the United States손경복Article
2020Pharmacogenomic Biomarkers and Their Applications in Psychiatry정호철Review
2019Public perceptions of the roles and functions of community pharmacies in the era of expanding scopes of pharmaceutical practice: A questionnaire survey in South Korea손경복Article
2020Recent trends in tablet subdivision and factors affecting subdivision in South Korea A cross-sectional study손경복Article
2020RNA-binding as chaperones of DNA binding proteins from starved cells정호철Article
2020The speed of adoption of new drugs and prescription volume after the amendments in reimbursement coverage: the case of non-vitamin K antagonist oral anticoagulants in South Korea손경복Article
2020Trends in the Utilization of Sodium Hyaluronate Eye Drops, Including Disposable and Multiuse Forms, in South Korea: A 14-Year Longitudinal Retrospective Cohort Study손경복Article
2018Understanding the adoption of new drugs decided by several stakeholders in the South Korean market: A nonparametric event history analysis손경복Article
2020Understanding the trends in international agreements on pricing and reimbursement for newly marketed medicines and their implications for access to medicines: a computational text analysis손경복Article

BROWSE